The transcriptional signature of dioxin in human hepatoma HepG2 cells

Biochemical Pharmacology

Volumn 60, Issue 8, 2000, Pages 1129-1142

  Puga, Alvaro ^a   Maier, Andrew ^a   Medvedovic, Mario ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Ah receptor; Microarray hybridization; Signal transduction; TCDD; Transcriptional program

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; COMPLEMENTARY DNA; CYCLOHEXIMIDE; DIOXIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE; RAS PROTEIN; TRANSCRIPTION FACTOR;

CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE;

EID: 0034668144     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00403-2     Document Type: Article

References (188)

1. Suskind R.R. Chloracne, "the hallmark of dioxin intoxication." Scand J Work Environ Health. 11:1985;165-171.
2. Zugerman C. Chloracne. Clinical manifestations and etiology. Dermatol Clin. 8:1990;209-213.
3. Bertazzi PA, Long-term effects of chemical disasters. Lessons and results from Seveso. Sci Total Environ 106: 5-20, 1991.
4. Manz A., Berger J., Dwyer J.H., Flesch-Janys D., Nagel S., Waltsgott H. Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet. 338:1991;959-964.
5. Bertazzi P.A., Pesatori A.C., Consonni D., Tironi A., Landi M.T., Zocchetti C. Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin. Epidemiology. 4:1993;398-406.
6. Fingerhut M.A., Halperin W.E., Marlow D.A., Piacitelli L.A., Honchar P.A., Sweeney M.H., Greife A.L., Dill P.A., Steenland K., Suruda A.J. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N Engl J Med. 324:1991;212-218.
7. Flesch-Janys D., Berger J., Gurn P., Manz A., Nagel S., Waltsgott H., Dwyer J.H. Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany. Am J Epidemiol. 142:1995;1165-1175.
8. Steenland K., Piacitelli L., Deddens J., Fingerhut M., Chang L.I. Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Natl Cancer Inst. 91:1999;779-786.
9. Rier S.E., Martin D.C., Bowman R.E., Dmowski W.P., Becker J.L. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 21:1993;433-441.
10. Cummings A.M., Metcalf J.L., Birnbaum L. Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice Time-dose dependence and species comparison . Toxicol Appl Pharmacol. 138:1996;131-139.
11. Yoshida K., Ikeda S., Nakanishi J. Assessment of human health risk of dioxins in Japan. Chemosphere. 40:2000;177-185.
12. Birnbaum L.S. Developmental effects of dioxins. Environ Health Perspect. 103:(Suppl 7):1995;89-94.
13. Couture L.A., Abbott B.D., Birnbaum L.S. A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin Recent advances toward understanding the mechanism . Teratology. 42:1990;619-627.
14. Abbott B.D. Review of the interaction between TCDD and glucocorticoids in embryonic palate. Toxicology. 105:1995;365-373.
15. Kociba R.J., Keyes D.G., Beyer J.E., Carreon R.M., Wade C.E., Dittenber D.A., Kalnins R.P., Frauson L.E., Park C.N., Barnard S.D., Hummel R.A., Humiston C.G. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 46:1978;279-303.
16. Brown N.M., Manzolillo P.A., Zhang J.X., Wang J., Lamartiniere C.A. Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis. 19:1998;1623-1629.
17. Hengstler J.G., Van der Burg B., Steinberg P., Oesch F. Interspecies differences in cancer susceptibility and toxicity. Drug Metab Rev. 31:1999;917-970.
18. Hornung M.W., Spitsbergen J.M., Peterson R.E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters cardiovascular and craniofacial development and function in sac fry of rainbow trout (Oncorhynchus mykiss). Toxicol Sci. 47:1999;40-51.
19. Guiney P.D., Smolowitz R.M., Peterson R.E., Stegeman J.J. Correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in vascular endothelium with toxicity in early life stages of lake trout. Toxicol Appl Pharmacol. 143:1997;256-273.
20. Oughton J.A., Pereira C.B., DeKrey G.K., Collier J.M., Frank A.A., Kerkvliet N.I. Phenotypic analysis of spleen, thymus, and peripheral blood cells in aged C57BI/6 mice following long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 25:1995;60-69.
21. Bjerke D.L., Peterson R.E. Reproductive toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male rats Different effects of in utero versus lactational exposure . Toxicol Appl Pharmacol. 127:1994;241-249.
22. Bjerke D.L., Brown T.J., MacLusky N.J., Hochberg R.B., Peterson R.E. Partial demasculinization and feminization of sex behavior in male rats by in utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin is not associated with alterations in estrogen receptor binding or volumes of sexually differentiated brain nuclei. Toxicol Appl Pharmacol. 127:1994;258-267.
23. Cummings A.M., Metcalf J.L., Birnbaum L. Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice Time-dose dependence and species comparison . Toxicol Appl Pharmacol. 138:1996;131-139.
24. Mably T.A., Bjerke D.L., Moore R.W., Gendron-Fitzpatrick A., Peterson R.E. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 3. Effects on spermatogenesis and reproductive capability. Toxicol Appl Pharmacol. 114:1992;118-126.
25. Kerkvliet N.I., Steppan L.B., Brauner J.A., Deyo J.A., Henderson M.C., Tomar R.S., Buhler D.R. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin Evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression . Toxicol Appl Pharmacol. 105:1990;26-36.
26. Kerkvliet N.I. Immunological effects of chlorinated dibenzo-p-dioxins. Environ Health Perspect. 103:1995;47-53.
27. Kerkvliet N.I. Immunological effects of chlorinated dibenzo-p-dioxins. Environ Health Perspect. 103:(Suppl 9):1995;47-53.
28. Safe S., Wang F., Porter W., Duan R., McDougal A. Ah receptor agonists as endocrine disruptors Antiestrogenic activity and mechanisms . Toxicol Lett. 102-103:1998;343-347.
29. Safe S.H. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol Ther. 67:1995;247-281.
30. Milstone L.M., LaVigne J.F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces hyperplasia in confluent cultures of human keratinocytes. J Invest Dermatol. 82:1984;532-534.
31. Moolgavkar S., Luebeck E.G., Buchmann A., Bock K.W. Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol. 138:1996;31-42.
32. Wiebel F.J., Klose U., Kiefer F. Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in vitro H4IIEC3-derived 5L hepatoma cells as a model system . Toxicol Lett. 55:1991;161-169.
33. Göttlicher M., Wiebel F.J. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes unbalanced growth in 5L rat hepatoma cells. Toxicol Appl Pharmacol. 111:1991;496-503.
34. Wölfle D., Becker E., Schmutte C. Growth stimulation of primary rat hepatocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cell Biol Toxicol. 9:1993;15-31.
35. Gaido K.W., Maness S.C., Leonard L.S., Greenlee W.F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-alpha and -beta 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J Biol Chem. 267:1992;24591-24595.
36. Gaido K.W., Maness S.C. Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol. 127:1994;199-208.
37. Gaido K.W., Maness S.C. Post-transcriptional stabilization of urokinase plasminogen activator mRNA by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a human keratinocyte cell line. Toxicol Appl Pharmacol. 133:1995;34-42.
38. Choi E.J., Toscano D.G., Ryan J.A., Riedel N., Toscano W.A. Jr. Dioxin induces transforming growth factor-alpha in human keratinocytes. J Biol Chem. 266:1991;9591-9597.
39. 2+-mediated endonuclease activation. Science. 242:1988;256-259.
40. McConkey D.J., Orrenius S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin kills glucocorticoid-sensitive thymocytes in vivo. Biochem Biophys Res Commun. 160:1989;1003-1008.
41. Kamath A.B., Xu H., Nagarkatti P.S., Nagarkatti M. Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol. 142:1997;367-377.
42. Worner W., Schrenk D. Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1. Cancer Res. 56:1996;1272-1278.
43. Nebert D.W. The Ah locus Genetic differences in toxicity, cancer, mutation, and birth defects . Crit Rev Toxicol. 20:1989;153-174.
44. Sutter T.R., Greenlee W.F. Classification of members of the Ah gene battery. Chemosphere. 25:1992;223-226.
45. Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol. 35:1995;307-340.
46. Wang X., Harris P.K., Ulrich R., Voorman R.L. Identification of dioxin-responsive genes in HepG2 cells using differential mRNA display RT-PCR. Biochem Biophys Res Commun. 220:1996;784-788.
47. Sutter T.R., Guzman K., Dold K.M., Greenlee W.F. Targets for dioxin Genes for plasminogen activator inhibitor-2 and interleukin-1 beta . Science. 254:1991;415-418.
48. Hoffer A., Chang C.-Y., Puga A. Dioxin induces fos and jun gene expression by Ah receptor-dependent and -independent-pathways. Toxicol Appl Pharmacol. 141:1996;238-247.
49. Puga A., Nebert D.W., Carrier F. Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol. 11:1992;269-281.
50. Puga A., Hoffer A., Zhou S., Bohm J.M., Leikauf G.D., Shertzer H.G. Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem Pharmacol. 54:1997;1287-1296.
51. Kraemer S.A., Arthur K.A., Denison M.S., Smith W.L., DeWitt D.L. Regulation of prostaglandin endoperoxide H synthase-2 expression by 2,3,7,8,-tetrachlorodibenzo-p-dioxin. Arch Biochem Biophys. 330:1996;319-328.
52. Olnes M.J., Verma M., Kurl R.N. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates expression of the prostaglandin G/H synthase-2 gene in rat thymocytes. J Pharmacol Exp Ther. 279:1996;1566-1573.
53. Liu Y., Levy G.N., Weber W.W. Induction of human prostaglandin endoperoxide H synthase-2 (PHS-2) mRNA by TCDD. Prostaglandins. 53:1997;1-10.
54. Vogel C., Schuhmacher U.S., Degen G.H., Bolt H.M., Pineau T., Abel J. Modulation of prostaglandin H synthase-2 mRNA expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice. Arch Biochem Biophys. 351:1998;265-271.
55. Wolfle D., Marotzki S., Dartsch D., Schafer W., Marquardt H. Induction of cyclooxygenase expression and enhancement of malignant cell transformation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis. 21:2000;15-21.
56. Lee C.A., Lawrence B.P., Kerkvliet N.I., Rifkind A.B. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P450-dependent arachidonic acid metabolism in mouse liver microsomes Evidence for species-specific differences in responses . Toxicol Appl Pharmacol. 153:1998;1-11.
57. Connor M.J., Nanthur J., Puhvel S.M. Influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on TNF-alpha levels in the skin of congenic haired and hairless mice. Toxicol Appl Pharmacol. 129:1994;12-15.
58. Vogel C., Abel J. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on growth factor expression in the human breast cancer cell line MCF-7. Arch Toxicol. 69:1995;259-265.
59. Fan F., Yan B., Wood G., Viluksela M., Rozman K.K. Cytokines (IL-1beta and TNFalpha) in relation to biochemical and immunological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology. 116:1997;9-16.
60. Moos A.B., Oughton J.A., Kerkvliet N.I. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on tumor necrosis factor (TNF) production by peritoneal cells. Toxicol Lett. 90:1997;145-153.
61. De Haan L.H., Simons J.W., Bos A.T., Aarts J.M., Denison M.S., Brouwer A. Inhibition of intercellular communication by 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like PCBs in mouse hepatoma cells (Hepa1c1c7) Involvement of the Ah receptor . Toxicol Appl Pharmacol. 129:1994;283-293.
62. Park J.Y., Shigenaga M.K., Ames B.N. Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage. Proc Natl Acad Sci USA. 19:1996;2322-2327.
63. Shertzer H.G., Nebert D.W., Puga A., Ary M., Sonntag D., Dixon K., Robinson L.J., Cianciolo E., Dalton T.P. TCDD causes a sustained oxidative stress response in C57BL/6J mice. Biochem Biophys Res Commun. 253:1998;44-48.
64. Stohs S.J., Shara M.A., Alsharif N.Z., Wahba Z.Z., al-Bayati Z.A. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced oxidative stress in female rats. Toxicol Appl Pharmacol. 106:1990;126-135.
65. Schiestl R.H., Aubrecht J., Yap W.Y., Kandikonda S., Sidhom S. Polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin induce intrachromosomal recombination in vitro and in vivo. Cancer Res. 57:1997;4378-4383.
66. Weiss C., Kolluri S.K., Kiefer F., Gottlicher M. Complementation of Ah receptor deficiency in hepatoma cells Negative feedback regulation and cell cycle control by the Ah receptor . Exp Cell Res. 226:1996;154-163.
67. Gottlicher M., Cikryt P. Induction of the aromatic hydrocarbon receptor by trans-4-acetylaminostilbene in rat liver. Comparison with other aromatic amines. Carcinogenesis. 8:1987;1021-1023.
68. Ma Q., Whitlock J.P. Jr. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol. 16:1996;2144-2150.
69. kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 13:1999;1742-1753.
70. Rininger J., Ma X., Babish J.G. Increased hepatic expression and phosphorylation of the murine p53 tumor suppressor protein and expression of p21WAF1 CDK-inhibitory protein following acute dosing of TCDD. Proc 15th Int Symp Chlor Dioxins. 25:1995;367-372.
71. Ma X., Babish J.G. Acute 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure results in enhanced tyrosylphosphorylation and expression of murine hepatic cyclin dependent kinases. Biochem Biophys Res Commun. 197:1993;1070-1077.
72. Ge N.-L., Elferink C.J. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle. J Biol Chem. 273:1998;22708-22713.
73. Puga A., Barnes S.J., Dalton T.P., Chang C., Knudsen E.S., Maier M.A. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J Biol Chem. 275:2000;2943-2950.
74. Reiners J.J. Jr, Clift R.E. Aryl hydrocarbon receptor regulation of ceramide-induced apoptosis in murine hepatoma 1c1c7 cells. J Biol Chem. 274:1999;2502-2510.
75. Braxton S., Bedilion T. The integration of microarray information in the drug development process. Curr Opin Biotechnol. 9:1998;643-649.
76. Sadhu D.N., Merchant M., Safe S.H., Ramos K.S. Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo[a]pyrene. Arch Biochem Biophys. 300:1993;124-131.
77. Bral C.M., Ramos K.S. Identification of benzo[a]pyrene-inducible cis-acting elements within c-Ha-ras transcriptional regulatory sequences. Mol Pharmacol. 52:1997;974-982.
78. Canga L., Paroli L., Blanck T.J., Silver R.B., Rifkind A.B. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick embryo hearts. Mol Pharmacol. 44:1993;1142-1151.
79. Tian Y., Ke S., Denison M.S., Rabson A.B., Gallo M.A. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J Biol Chem. 274:1999;510-515.
80. Puga A., Barnes S.J., Chang C., Zhu H., Nephew K.P., Khan S.A., Shertzer H.G. Activation of transcription factors activator protein-1 and nuclear factor-kappaB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Pharmacol. 59:2000;997-1005.
81. Ramos K.S., Parrish A.R. Growth-related signaling as a target of toxic insult in vascular smooth muscle cells Implications in atherogenesis . Life Sci. 57:1995;627-635.
82. Bombick D.W., Matsumura F., Madhukar B.V. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes reduction in the low density lipoprotein (LDL) receptor activities in the hepatic plasma membrane of the guinea pig and rat. Biochem Biophys Res Commun. 118:1984;548-554.
83. Roman B.L., Pollenz R.S., Peterson R.E. Responsiveness of the adult male rat reproductive tract to 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure Ah receptor and ARNT expression, CYP1A1 induction, and Ah receptor down-regulation . Toxicol Appl Pharmacol. 150:1998;228-239.
84. Sommer R.J., Ippolito D.L., Peterson R.E. In utero and lactational exposure of the male Holtzman rat to 2,3,7,8-tetrachlorodibenzo-p-dioxin Decreased epididymal and ejaculated sperm numbers without alterations in sperm transit rate . Toxicol Appl Pharmacol. 140:1996;146-153.
85. Matsumura F., Brewster D.W., Madhukar B.V., Bombick D.W. Alteration of rat hepatic plasma membrane functions by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Arch Environ Contam Toxicol. 13:1984;509-515.
86. Katz M.E., McCormick F. Signal transduction from multiple Ras effectors. Curr Opin Genet Dev. 7:1997;75-79.
87. Comoglio P.M., Tamagnone L., Boccaccio C. Plasminogen-related growth factor and semaphorin receptors A gene superfamily controlling invasive growth . Exp Cell Res. 253:1999;88-99.
88. Joseph S.K. The inositol triphosphate receptor family. Cell Signal. 8:1996;1-7.
89. Zhou G., Bao Z.Q., Dixon J.E. Components of a new human protein kinase signal transduction pathway. J Biol Chem. 270:1995;12665-12669.
90. Tocque B., Delumeau I., Parker F., Maurier F., Multon M.C., Schweighoffer F. Ras-GTPase activating protein (GAP) A putative effector for Ras . Cell Signal. 9:1997;153-158.
91. Kwiatkowski D.J. Functions of gelsolin Motility, signaling, apoptosis, cancer . Curr Opin Cell Biol. 11:1999;103-108.
92. Guerra B., Issinger O.G. Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis. 20:1999;391-408.
93. Zhu A.X., Zhao Y., Flier J.S. Molecular cloning of two small GTP-binding proteins from human skeletal muscle. Biochem Biophys Res Commun. 205:1994;1875-1882.
94. Inagaki K., Noguchi T., Matozaki T., Horikawa T., Fukunaga K., Tsuda M., Ichihashi M., Kasuga M. Roles for the protein tyrosine phosphatase SHP-2 in cytoskeletal organization, cell adhesion and cell migration revealed by overexpression of a dominant negative mutant. Oncogene. 19:2000;75-84.
95. Kyriakis J.M., Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays. 18:1996;567-577.
96. Vanhaesebroeck B., Waterfield M.D. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res. 253:1999;239-254.
97. Bingham C.O. 3rd, Austen K.F. Phospholipase A2 enzymes in eicosanoid generation. Proc Assoc Am Physicians. 111:1999;516-524.
98. Holloway M.P., Bram R.J. Co-localization of calcium-modulating cyclophilin ligand with intracellular calcium pools. J Biol Chem. 273:1998;16346-16350.
99. Xu L., Tripathy A., Pasek D.A., Meissner G. Potential for pharmacology of ryanodine receptor/calcium release channels. Ann N Y Acad Sci. 853:1998;130-148.
100. 2+-calmodulin and protein kinase Cs A hypothetical synthesis of their conflicting convergences on shared substrate domains . Trends Neurosci. 22:1999;12-16.
101. Kanoh H., Kai M., Wada I. Molecular characterization of the type 2 phosphatidic acid phosphatase. Chem Phys Lipids. 98:1999;119-126.
102. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta. 1450:1999;191-231.
103. Lee J., Wang Z., Luoh S.M., Wood W.I., Scadden D.T. Cloning of FRK, a novel human intracellular SRC-like tyrosine kinase-encoding gene. Gene. 138:1994;247-251.
104. Morioka M., Hamada J., Ushio Y., Miyamoto E. Potential role of calcineurin for brain ischemia and traumatic injury. Prog Neurobiol. 58:1999;1-30.
105. Braunewell K.H., Gundelfinger E.D. Intracellular neuronal calcium sensor proteins A family of EF-hand calcium-binding proteins in search of a function . Cell Tissue Res. 295:1999;1-12.
106. Bluhm W.F., Kranias E.G., Dillmann W.H., Meyer M. Phospholamban A major determinant of the cardiac force-frequency relationship . Am J Physiol Heart Circ Physiol. 278:2000;H249-H255.
107. Orlov S.N., Li J.M., Tremblay J., Hamet P. Genes of intracellular calcium metabolism and blood pressure control in primary hypertension. Semin Nephrol. 15:1995;569-592.
108. Means A.R. Calcium, calmodulin and cell cycle regulation. FEBS Lett. 347:1994;1-4.
109. Weil R., Veillette A. Signal transduction by the lymphocyte-specific tyrosine protein kinase p56lck. Curr Top Microbiol Immunol. 205:1996;63-87.
110. Fournier E., Birnbaum D., Borg J.P. [Receptors for factors for the VEGF]. Bull Cancer. 84:1997;397-405.
111. Park J.Y., Ha S.W., King G.L. The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Perit Dial Int. 19:(Suppl 2):1999;S222-S227.
112. Bowie A., O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation A reassessment of the evidence in the light of recent discoveries . Biochem Pharmacol. 59:2000;13-23.
113. Akiyama S.K. Integrins in cell adhesion and signaling. Hum Cell. 9:1996;181-186.
114. Velasco-Velazquez M.A., Molina-Guarneros J.A., Mendoza-Patino N., Sullivan Lopez J., Mandoki J.J. [Integrins and integrin-associated molecules Targets for the development of antimetastatic therapies] . Rev Invest Clin. 51:1999;183-193.
115. Winder W.W., Hardie D.G. AMP-activated protein kinase, a metabolic master switch Possible roles in type 2 diabetes . Am J Physiol. 277:1999;E1-E10.
116. Gehrmann T., Heilmeyer L.M. Jr. Phosphatidylinositol 4-kinases. Eur J Biochem. 253:1998;357-370.
117. Tibbles L.A., Woodgett J.R. The stress-activated protein kinase pathways. Cell Mol Life Sci. 55:1999;1230-1254.
118. Scott J.D., Dell'Acqua M.L., Fraser I.D., Tavalin S.J., Lester L.B. Coordination of cAMP signaling events through PKA anchoring. Adv Pharmacol. 47:2000;175-207.
119. Garcia K.C. Molecular interactions between extracellular components of the T-cell receptor signaling complex. Immunol Rev. 172:1999;73-85.
120. Sato Y. Transcription factor ETS-1 as a molecular target for angiogenesis inhibition. Hum Cell. 11:1998;207-214.
121. O'Donovan K.J., Tourtellotte W.G., Millbrandt J., Baraban J.M. The EGR family of transcription-regulatory factors Progress at the interface of molecular and systems neuroscience . Trends Neurosci. 22:1999;167-173.
122. McArthur G.A., Laherty C.D., Queva C., Hurlin P.J., Loo L., James L., Grandori C., Gallant P., Shiio Y., Hokanson W.C., Bush A.C., Cheng P.F., Lawrence Q.A., Pulverer B., Koskinen P.J., Foley K.P., Ayer D.E., Eisenman R.N. The Mad protein family links transcriptional repression to cell differentiation. Cold Spring Harb Symp Quant Biol. 63:1998;423-433.
123. Shore P., Sharrocks A.D. The MADS-box family of transcription factors. Eur J Biochem. 229:1995;1-13.
124. Wodarz A., Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol. 14:1998;59-88.
125. Pierrou S., Hellqvist M., Samuelsson L., Enerback S., Carlsson P. Cloning and characterization of seven human forkhead proteins Binding site specificity and DNA bending . EMBO J. 13:1994;5002-5012.
126. Loskutoff D.J., Curriden S.A., Hu G., Deng G. Regulation of cell adhesion by PAI-1. APMIS. 107:1999;54-61.
127. Filatov V.L., Katrukha A.G., Bulargina T.V., Gusev N.B. Troponin Structure, properties, and mechanism of functioning . Biochemistry (Mosc). 64:1999;969-985.
128. Wang J.H., Redmond H.P., Wu Q.D., Bouchier-Hayes D. Nitric oxide mediates hepatocyte injury. Am J Physiol. 275:1998;G1117-G1126.
129. Sharma R., Coats A.J., Anker S.D. The role of inflammatory mediators in chronic heart failure Cytokines, nitric oxide, and endothelin-1 . Int J Cardiol. 72:2000;175-186.
130. Vinten-Johansen J., Zhao Z.Q., Nakamura M., Jordan J.E., Ronson R.S., Thourani V.H., Guyton R.A. Nitric oxide and the vascular endothelium in myocardial ischemia-reperfusion injury. Ann N Y Acad Sci. 874:1999;354-370.
131. Kozaki K., Ouchi Y. Activin/follistatin and atherosclerosis - a review. J Atheroscler Thromb. 5:1998;36-40.
132. Clark D.A., Arck P.C., Chaouat G. Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level. Am J Reprod Immunol. 41:1999;5-22.
133. Fujiwara T.M., Morgan K., Bichet D.G. Molecular biology of diabetes insipidus. Annu Rev Med. 46:1995;331-343.
134. Ziboh V.A., Miller C.C., Cho Y. Metabolism of polyunsaturated fatty acids by skin epidermal enzymes Generation of antiinflammatory and antiproliferative metabolites . Am J Clin Nutr. 71:2000;361S-366S.
135. Zhang N., Deuel T.F. Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors. Curr Opin Hematol. 6:1999;44-50.
136. Hussain M.M., Strickland D.K., Bakillah A. The mammalian low-density lipoprotein receptor family. Annu Rev Nutr. 19:1999;141-172.
137. Citarella F., Misiti S., Felici A., Farsetti A., Pontecorvi A., Fantoni A. Estrogen induction and contact phase activation of human factor XII. Steroids. 61:1996;270-276.
138. Shine J., Potter E.K., Biden T., Selbie L.A., Herzog H. Neuropeptide Y and regulation of the cardiovascular system. J Hypertens Suppl. 12:1994;S41-S45.
139. Schaper W., Buschmann I. VEGF and therapeutic opportunities in cardiovascular diseases. Curr Opin Biotechnol. 10:1999;541-543.
140. McCormick C., Duncan G., Tufaro F. New perspectives on the molecular basis of hereditary bone tumours. Mol Med Today. 5:1999;481-486.
141. Buchanan M.R., Brister S.J. A rationale for targeting antithrombotic therapy at the vessel wall Improved antithrombotic effect and decreased risk of bleeding . Wien Klin Wochenschr. 111:1999;81-89.
142. Kovanen P.T., Pentikainen M.O. Decorin links low-density lipoproteins (LDL) to collagen A novel mechanism for retention of LDL in the atherosclerotic plaque . Trends Cardiovasc Med. 9:1999;86-91.
143. Narayanan S. Multifunctional roles of thrombin. Ann Clin Lab Sci. 29:1999;275-280.
144. Blink E.J., Trapani J.A., Jans D.A. Perforin-dependent nuclear targeting of granzymes A central role in the nuclear events of granule-exocytosis-mediated apoptosis? Immunol Cell Biol. 77:1999;206-215.
145. Ohi R., Gould K.L. Regulating the onset of mitosis. Curr Opin Cell Biol. 11:1999;267-273.
146. Davey S., Beach D. RACH2, a novel human gene that complements a fission yeast cell cycle checkpoint mutation. Mol Biol Cell. 6:1995;1411-1421.
147. Deak F., Wagener R., Kiss I., Paulsson M. The matrilins A novel family of oligomeric extracellular matrix proteins . Matrix Biol. 18:1999;55-64.
148. Gotzmann J., Foisner R. Lamins and lamin-binding proteins in functional chromatin organization. Crit Rev Eukaryot Gene Expr. 9:1999;257-265.
149. Ballou L.R., Laulederkind S.J., Rosloniec E.F., Raghow R. Ceramide signalling and the immune response. Biochim Biophys Acta. 1301:1996;273-287.
150. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 15:1999;269-290.
151. McCarty M.F. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity Down-regulation with essential fatty acids, ethanol and pentoxifylline . Med Hypotheses. 52:1999;465-477.
152. Kawakami T., Furukawa Y., Sudo K., Saito H., Takami S., Takahashi E., Nakamura Y. Isolation and mapping of a human gene (PDCD2) that is highly homologous to Rp8, a rat gene associated with programmed cell death. Cytogenet Cell Genet. 71:1995;41-43.
153. Dinarello C.A. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci. 856:1998;1-11.
154. Rath P.C., Aggarwal B.B. TNF-induced signaling in apoptosis. J Clin Immunol. 19:1999;350-364.
155. Grana X., Garriga J., Mayol X. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene. 17:1998;3365-3383.
156. Szatmary Z. Tumor necrosis factor-alpha Molecular-biological aspects minireview . Neoplasma. 46:1999;257-266.
157. Woodgett J.R. Regulation and functions of the glycogen synthase kinase-3 subfamily. Semin Cancer Biol. 5:1994;269-275.
158. Shtivelman E. A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene. 14:1997;2167-2173.
159. Del Sal G., Collavin L., Ruaro M.E., Edomi P., Saccone S., Valle G.D., Schneider C. Structure, function, and chromosome mapping of the growth-suppressing human homologue of the murine gas1 gene. Proc Natl Acad Sci USA. 91:1994;1848-1852.
160. Grootegoed J.A., Baarends W.M., Themmen A.P. Welcome to the family The anti-mullerian hormone receptor . Mol Cell Endocrinol. 100:1994;29-34.
161. Kelley W.L. The J-domain family and the recruitment of chaperone power. Trends Biochem Sci. 23:1998;222-227.
162. Fry A.M., Arnaud L., Nigg E.A. Activity of the human centrosomal kinase, Nek2, depends on an unusual leucine zipper dimerization motif. J Biol Chem. 274:1999;16304-16310.
163. Pasternak G., Hochhaus A., Schultheis B., Hehlmann R. Chronic myelogenous leukemia Molecular and cellular aspects . J Cancer Res Clin Oncol. 124:1998;643-660.
164. McKendrick L., Pain V.M., Morley S.J. Translation initiation factor 4E. Int J Biochem Cell Biol. 31:1999;31-35.
165. Thaler J., Harrison K., Sharma K., Lettieri K., Kehrl J., Pfaff S.L. Active suppression of interneuron programs within developing motor neurons revealed by analysis of homeodomain factor HB9. Neuron. 23:1999;675-687.
166. Dahl E., Koseki H., Balling R. Pax genes and organogenesis. Bioessays. 19:1997;755-765.
167. Tribioli C., Lufkin T. The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development. 126:1999;5699-5711.
168. Panaretto B.A. Gene expression of potential morphogens during hair follicle and tooth formation A review . Reprod Fertil Dev. 5:1993;345-360.
169. Killeen N. T-cell regulation Thy-1-hiding in full view . Curr Biol. 7:1997;R774-R777.
170. Parkos C.A. Cell adhesion and migration. I. Neutrophil adhesive interactions with intestinal epithelium. Am J Physiol. 273:1997;G763-G768.
171. Kinoshita T., Inoue N., Takeda J. Role of phosphatidylinositol-linked proteins in paroxysmal nocturnal hemoglobinuria pathogenesis. Annu Rev Med. 47:1996;1-10.
172. Herscovics A. Importance of glycosidases in mammalian glycoprotein biosynthesis. Biochim Biophys Acta. 1473:1999;96-107.
173. Wong S.H., Zhang T., Xu Y., Subramaniam V.N., Griffiths G., Hong W. Endobrevin, a novel synaptobrevin/VAMP-like protein preferentially associated with the early endosome. Mol Biol Cell. 9:1998;1549-1563.
174. De Matteis M.A., Morrow J.S. The role of ankyrin and spectrin in membrane transport and domain formation. Curr Opin Cell Biol. 10:1998;542-549.
175. Rebouche C.J. Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr. 54:1991;1147S-1152S.
176. Los D.A., Murata N. Structure and expression of fatty acid desaturases. Biochim Biophys Acta. 1394:1998;3-15.
177. Dooley T.P. Molecular biology of the human cytosolic sulfotransferase gene superfamily implicated in the bioactivation of minoxidil and cholesterol in skin. Exp Dermatol. 8:1999;328-329.
178. Kaina B., Fritz G., Ochs K., Haas S., Grombacher T., Dosch J., Christmann M., Lund P., Gregel C.M., Becker K. Transgenic systems in studies on genotoxicity of alkylating agents Critical lesions, thresholds and defense mechanisms . Mutat Res. 405:1998;179-191.
179. Ishii T., Itoh K., Sato H., Bannai S. Oxidative stress-inducible proteins in macrophages. Free Radic Res. 31:1999;351-355.
180. Scharrer E. Control of food intake by fatty acid oxidation and ketogenesis. Nutrition. 15:1999;704-714.
181. Hartzog G.A., Basrai M.A., Ricupero-Hovasse S.L., Hieter P., Winston F. Identification and analysis of a functional human homolog of the SPT4 gene of Saccharomyces cerevisiae. Mol Cell Biol. 16:1996;2848-2856.
182. Pasqualini JR, Schatz B, Varin C and Nguyen BL, Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer [published erratum appears in J Steroid Biochem Mol Biol 42: 251, 1992]. J Steroid Biochem Mol Biol 41: 323-329, 1992.
183. Pasqualini JR, Schatz B, Varin C and Nguyen BL, Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer [published erratum appears in J Steroid Biochem Mol Biol 42: 251, 1992]. J Steroid Biochem Mol Biol 41: 323-329, 1992.
184. Fishel R., Wilson T. MutS homologs in mammalian cells. Curr Opin Genet Dev. 7:1997;105-113.
185. Prats E., Noel M., Letourneau J., Tiranti V., Vaque J., Debon R., Zeviani M., Cornudella L., Ruiz-Carrillo A. Characterization and expression of the mouse endonuclease G gene. DNA Cell Biol. 16:1997;1111-1122.
186. Cai J., Jones D.P. Mitochondrial redox signaling during apoptosis. J Bioenerg Biomembr. 31:1999;327-334.
187. Weisberg E., Sattler M., Ewaniuk D.S., Salgia R. Role of focal adhesion proteins in signal transduction and oncogenesis. Crit Rev Oncog. 8:1997;343-358.
188. Miyoshi E., Noda K., Yamaguchi Y., Inoue S., Ikeda Y., Wang W., Ko J.H., Uozumi N., Li W., Taniguchi N. The alpha1-6-fucosyltransferase gene and its